[1] 段晓燕,范建高. 2010年亚太肝病学会非酒精性脂肪性肝病纪要. 实用肝脏病杂志,2010,13(5):241-244. [2] 陈民,李玉晓,李莉. 平顶山市公务员非酒精性脂肪肝和代谢性综合征相关性调查研究. 中国实用医药,2012,7(20):273-274. [3] 俞琳. 代谢综合征与非酒精性脂肪肝关系分析. 现代中西医结合杂志,2012,21(25):2792-2793. [4] 许嘉,艾丽艳. 北京市某区卫生防疫人群非酒精性脂肪肝危险因素分析. 首都公共卫生,2012,6(1):6-10. [5] Yan HM,Gao X,Liu M,et al. Study of the association between nonalcoholic fatty liver disease and metabolic syndrome. Chin J Diabetes,2006,14(5):326-328. [6] 周永健. 广东省成人代谢综合征与非酒精性脂肪肝患病的关系.胃肠病学与肝病学杂志,2008,17(80):647-649. [7] 岳冬梅. ALT升高、非酒精性脂肪肝与高血压病发病关系及可能机制探讨. 中国实用医药,2011,6(35):56-57. [8] Lopez-Suarez Auerrero JM,Elvira Gonzalez J.Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol,2011,23(11):1011-1017. [9] 钱雪梅,胡洁华. 还原型谷胱甘肽联合易善复治疗非酒精性脂肪肝的疗效观察. 中国医药指南,2012,10(21):537-538. |